COVID-BioB Cohort Study: the neutralizing antibody response to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for virus control and survival
View ORCID ProfileStefania Dispinseri, View ORCID ProfileMassimiliano Secchi, View ORCID ProfileMaria Franca Pirillo, View ORCID ProfileMonica Tolazzi, View ORCID ProfileMartina Borghi, View ORCID ProfileCristina Brigatti, View ORCID ProfileMaria Laura De Angelis, View ORCID ProfileMarco Baratella, View ORCID ProfileElena Bazzigaluppi, View ORCID ProfileGiulietta Venturi, Francesca Sironi, View ORCID ProfileAndrea Canitano, View ORCID ProfileIlaria Marzinotto, View ORCID ProfileCristina Tresoldi, View ORCID ProfileFabio Ciceri, View ORCID ProfileLorenzo Piemonti, View ORCID ProfileDonatella Negri, View ORCID ProfileAndrea Cara, View ORCID ProfileVito Lampasona, View ORCID ProfileGabriella Scarlatti
doi: https://doi.org/10.1101/2021.02.17.21251929
Stefania Dispinseri
1Viral Evolution and Transmission Unit, IRCCS Ospedale San Raffaele, Milan, Italy
PhDMassimiliano Secchi
2Diabetes Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy
PhDMaria Franca Pirillo
3National Center for Global Health, Istituto Superiore di Sanità, Rome, Italy
PhDMonica Tolazzi
1Viral Evolution and Transmission Unit, IRCCS Ospedale San Raffaele, Milan, Italy
MScMartina Borghi
4Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy
BScCristina Brigatti
2Diabetes Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy
MScMaria Laura De Angelis
5Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy
PhDMarco Baratella
1Viral Evolution and Transmission Unit, IRCCS Ospedale San Raffaele, Milan, Italy
PhDElena Bazzigaluppi
2Diabetes Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy
MScGiulietta Venturi
4Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy
PhDFrancesca Sironi
1Viral Evolution and Transmission Unit, IRCCS Ospedale San Raffaele, Milan, Italy
MScAndrea Canitano
3National Center for Global Health, Istituto Superiore di Sanità, Rome, Italy
PhDIlaria Marzinotto
2Diabetes Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy
PhDCristina Tresoldi
6Molecular Hematology Unit, IRCCS Ospedale San Raffaele, Milan, Italy
MScFabio Ciceri
7Hematology and Bone Marrow Transplantation Unit, IRCCS Ospedale San Raffaele, Milan, Italy
8School of Medicine and Surgery, Università Vita-Salute San Raffaele, Milan, Italy
MDLorenzo Piemonti
2Diabetes Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy
8School of Medicine and Surgery, Università Vita-Salute San Raffaele, Milan, Italy
MDDonatella Negri
4Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy
PhDAndrea Cara
3National Center for Global Health, Istituto Superiore di Sanità, Rome, Italy
PhDVito Lampasona
2Diabetes Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy
MScGabriella Scarlatti
1Viral Evolution and Transmission Unit, IRCCS Ospedale San Raffaele, Milan, Italy
MD![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data Availability
The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.
Posted February 19, 2021.
COVID-BioB Cohort Study: the neutralizing antibody response to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for virus control and survival
Stefania Dispinseri, Massimiliano Secchi, Maria Franca Pirillo, Monica Tolazzi, Martina Borghi, Cristina Brigatti, Maria Laura De Angelis, Marco Baratella, Elena Bazzigaluppi, Giulietta Venturi, Francesca Sironi, Andrea Canitano, Ilaria Marzinotto, Cristina Tresoldi, Fabio Ciceri, Lorenzo Piemonti, Donatella Negri, Andrea Cara, Vito Lampasona, Gabriella Scarlatti
medRxiv 2021.02.17.21251929; doi: https://doi.org/10.1101/2021.02.17.21251929
COVID-BioB Cohort Study: the neutralizing antibody response to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for virus control and survival
Stefania Dispinseri, Massimiliano Secchi, Maria Franca Pirillo, Monica Tolazzi, Martina Borghi, Cristina Brigatti, Maria Laura De Angelis, Marco Baratella, Elena Bazzigaluppi, Giulietta Venturi, Francesca Sironi, Andrea Canitano, Ilaria Marzinotto, Cristina Tresoldi, Fabio Ciceri, Lorenzo Piemonti, Donatella Negri, Andrea Cara, Vito Lampasona, Gabriella Scarlatti
medRxiv 2021.02.17.21251929; doi: https://doi.org/10.1101/2021.02.17.21251929
Subject Area
Subject Areas
- Addiction Medicine (342)
- Allergy and Immunology (665)
- Anesthesia (180)
- Cardiovascular Medicine (2625)
- Dermatology (222)
- Emergency Medicine (397)
- Epidemiology (12175)
- Forensic Medicine (10)
- Gastroenterology (756)
- Genetic and Genomic Medicine (4064)
- Geriatric Medicine (385)
- Health Economics (676)
- Health Informatics (2625)
- Health Policy (997)
- Hematology (360)
- HIV/AIDS (845)
- Medical Education (398)
- Medical Ethics (109)
- Nephrology (430)
- Neurology (3832)
- Nursing (209)
- Nutrition (570)
- Oncology (2008)
- Ophthalmology (581)
- Orthopedics (238)
- Otolaryngology (304)
- Pain Medicine (250)
- Palliative Medicine (73)
- Pathology (471)
- Pediatrics (1107)
- Primary Care Research (447)
- Public and Global Health (6499)
- Radiology and Imaging (1390)
- Respiratory Medicine (869)
- Rheumatology (400)
- Sports Medicine (338)
- Surgery (441)
- Toxicology (52)
- Transplantation (185)
- Urology (165)